Press release
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomics - Top Companies Regional and Data Analysis here
News-ID: 3825669 • Views: …
More Releases from The Insight Partners

Demineralized Whey Powder Market to Cross by 2031
New York, US - August 28, 2025 - The Insight Partners has announced the release of a new study titled "Demineralized Whey Powder Market Share, Size, Trends, and Forecast by 2031", predicting significant expansion in the global market. The report emphasizes how improved manufacturing technologies are elevating product standards and increasing market penetration. The global demineralized whey powder market is forecasted to grow from US$745.02 million in 2024 to US$1,068.30…

In-Vivo Imaging Camera Market Thrives on Real-Time Imaging
New York, US - August 28, 2025 - The global In-Vivo Imaging Camera Market is experiencing a transformative surge, propelled by innovations in imaging technology and expanding use in disease diagnosis and drug development. The latest In-Vivo Imaging Camera Market report from The Insight Partners, entitled "In-Vivo Imaging Camera Market Share, Size, Trends, and Forecast by 2031," provides a comprehensive overview of this rapidly growing market, projecting notable increases in…

Intelligent Pipeline Pigging Market Growth Trends: Global Analysis of Leading Pl …
According to the new research report published by The Insight Partners, titled "Intelligent Pipeline Pigging Market - A lot of hard work has been put together and no stone is left unturned while generating this market research report. This market research report is generated with a nice blend of industry insight, talent solutions, practical solutions and use of technology to advance user experience. It highlights public demands, competencies and the…

Infrastructure Solution Integration Service Market Poised for Significant Growth …
The Insight Partners has released a new report titled "Infrastructure Solution Integration Service Market Share, Size, Trends, and Forecast by 2031," forecasting strong growth for the global market. The report highlights how the increasing complexity of hybrid IT environments, the widespread push for digital transformation, and the demand for real-time data are accelerating industry demand. According to the Infrastructure Solution Integration Service Market forecast, the sector is set to experience…
More Releases for Pharmacogenomics
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…
Pharmacogenomics Market Worth $13.16 billion by 2029
Meticulous Research®-a leading global market research company, published a research report titled, 'Pharmacogenomics Market by Technology (PCR, Sequencing, Spectrometry, Electrophoresis), Application (Cancer, Cardiology, Neurology, Infectious Diseases), End User (Hospitals, Diagnostic Laboratories, Research Institutes)-Global Forecast to 2029.'
Download Free Research Sample @ https://www.meticulousresearch.com/download-sample-report/cp_id=5366
According to this latest publication from Meticulous Research®, the global pharmacogenomics market is projected to reach $13.16 billion by 2029, at a CAGR of 8.6% during the forecast period…